Home

A. Rachel Leheny

CIK 1484729 · CHIEF EXECUTIVE OFFICER · last filed 2026-06-29

A. Rachel Leheny is a CHIEF EXECUTIVE OFFICER who has filed 27 SEC Form 4 insider transactions across 4 companies since 2010. The most recent filing shows the insider was granted $150.0K of CALC on Jun 29, 2026. Across all open-market trades the lifetime net is +$914.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $275.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$275.6K

Companies

4

Total Filings

27

Lifetime Open-Market Net

$914.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CALC CHIEF EXECUTIVE OFFICER 383,883 $0.72 $275.6K $85.1K 20 2026-06-29
CalciMedica, Inc. (SCPH) Delisted CHIEF EXECUTIVE OFFICER 197,154 $5.67 $1.12M $79.2K 3 2024-11-01
CalciMedica, Inc. (GRAY) Delisted Chief Executive Officer 356,989 $5.50 $1.96M $0 1 2023-03-22
Anthera Pharmaceuticals Inc (ANTH) Delisted Director 22,248 — — $750.0K 3 2010-10-04

Recent Filings

27 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-29 CALC Grant (A) +186,729 $150.0K EDGAR
2026-04-07 CALC Grant (A) — $0 EDGAR
2025-07-21 CALC Buy (P) +1,000 $3.4K EDGAR
2025-07-15 CALC Buy (P) +2,500 $6.2K EDGAR
2025-06-26 CALC Grant (A) — $0 EDGAR
2025-04-25 CALC Grant (A) — $0 EDGAR
2024-11-01 CalciMedica, Inc. (SCPH) Delisted Buy (P) +20,000 $75.0K EDGAR
2024-08-28 CalciMedica, Inc. (SCPH) Delisted Grant (A) — $0 EDGAR
2024-08-27 CalciMedica, Inc. (SCPH) Delisted Buy (P) +1,000 $4.2K EDGAR
2024-04-22 CALC Grant (A) — $0 EDGAR
Showing 1–10 of 27
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.